Micap Share Discussion Threads

[unionhall] 14/10/2004 11:14

Lack of interest and low volumes I guess.

I bought in a couple of weeks ago. Will probably add as you say when there is a distinct reversal to the drop.

Problem I find with all these companies moving from development to commercialisation is the speed of sales(royalty) increase and how long to get to a profit situation.

I like the fact that Micap is not highly valued to start with, has low overheads(£1.8mpa) to allow an early move to profitability and a wide range of current and potential quality licencees(food, flavouring, pharma, insecticides and my favourite - anti smoking gum and films) .

But as always - how much, how soon ?

[matto] 14/10/2004 10:40

So why the drop today? Starting to look good value to me. May start building a position at these prices. Probably best to wait for the drop to start to reverse but will watch closely.

[unionhall] 11/10/2004 16:23

Micap to benefit from UK Government's Nanotechnology funding
for research into antimicrobial technology for urinary catheters
October 2004
Volume 1, Issue 5
common pathogens involved with colonization
of catheter surfaces during prolonged usage.
Production of an effective bacteriocidal and
bacteriostatic product based on essential oil/
biocide mixtures will demonstrate for the first
time two very important and unique properties -
a release on demand antimicrobial activity and
a broad spectrum biocidal treatment unlikely to
develop resistance.
Dr Gordon Nelson, Technical Director at
Micap, said: "We are delighted to receive the
award from the DTI. A successful outcome
could help the NHS to save millions of pounds
each year by reducing antibiotic use, in addition
to the potential for freeing up hospital
beds. The DTI support helps innovative
companies, such as Micap and Biomer, to turn
their ideas into reality, creating jobs and prosperity
for the companies
and the UK.
Device related infection
The use of medical
devices, such as catheters
has increased immensely
over the last
decade and it is predicted
that every person in a
technologically advanced
society will host at least
one implant in their lifetime.
Although this increase
in device use
has resulted in a better quality of life
and longer patient survival, device-related
infection has emerged as a major problem.
The attributable cost per infection is an
estimated $34,508--$56,000, and the annual
cost of caring for patients with catheterassociated
infections ranges from $296 million
to $2.3 billion. No effective therapies are
currently available for the treatment of devicerelated
infections; the effective treatment
often requires the removal of the device itself.
With a reduction of catheter related infections,
fewer invasive procedures for the patient will
be necessary resulting in better care and
ultimately a major cost saving to the healthcare
system.
Micap, the UK technology licensing company
specializing in the micro encapsulation of
active ingredients within yeast cells has been
awarded funding from the UK Government's
Micro and Nanotechnology manufacturing
initiative to carry out a development project
investigating the prevention of microbial
colonisation of polyurethane-based catheters.
The total project value is approximately
£260,000, and the new grants will cover 50%
of this cost. The funding is for a two year
project to develop the use of antimicrobial
technology from Manchester Metropolitan
University , polyurethane catheter technology
from Biomer Technologies Ltd; and Micap
PLC's yeast microencapsulation technology.
The development will focus on nosocomial
infections that represent an enormous financial
burden on healthcare
systems in terms of
extended hospital stay
and patient care. Many of
these infections are
catheter related and
bacteria are becoming
increasingly resistant to
most commonly used
antibiotics and antiseptics.
For example, each
year more than 1 million
patients in U.S. acutecare
hospitals and
extended-care facilities
acquire such an infection (Maki & Tambyah,
Emerging Infectious Diseases, Mar-Apr 01).
• This project will employ Micap's novel yeast
based micro-encapsulation technology, which
is able to protect volatile antimicrobials
through high temperature polymer production
and to control and target release of the antimicrobial
agent during the catheter lifetime.
• A combination of commercially available
biocides and antibacterial natural plant oils
such as tea tree oil will be used to overcome
problems of bacterial resistance.
The project will produce polyurethane based
catheter polymers that are able to demonstrate
effective antimicrobial activity against

[unionhall] 11/10/2004 16:04

Breaking News

Since the last newsletter, exciting new results in insecticide delivery
using the Micap™ technology have been found. More details
will be published in subsequent newsletters.
Micap's technical and business development team will also be
available to discuss opportunities using the Micap™ technology
at our stand (No.88) at the British Crop Protection Conference in
Glasgow, November 1st-3rd November 2004.

[jwe] 11/10/2004 15:43

October Newsletter from whom?

[unionhall] 11/10/2004 11:16

Look out for October Newsletter being published today...

[upshegoes] 22/9/2004 11:55

Up this morning on no volume,thoughts anyone?

[jwe] 16/9/2004 13:04

Large sell gone through,no movment in price,stock overhang maybe,any thoughts?

[grantb1] 15/9/2004 13:50

and a slight tick up Wezz

[wezzley] 15/9/2004 13:45

can only get about 600£ online

[wezzley] 15/9/2004 13:44

hotting up 2v1 might get in at 42.63

[relwood] 10/9/2004 08:30

Thanks for your thoughts. One to keep watching but high on my possible list. Good luck if you already hold.

[upshegoes] 09/9/2004 20:08

Great little company with a good future i think,
but have to admit i sold some of my holding today to put it somewhere a bit
shorter term for now.
Strange thing though,whenever i,ve tried to sell 5k or more before my broker
complains about nms and offers poor price after calling mm.
Today they gave me good price without complaint or calling mm, don,t know if
this means anything but seemed odd to me, any thoughts?

[beckaroo] 09/9/2004 19:45

Not enough buyers even with all the good news but some persistent sellers. The September newsletter is out on their website, its all about the agriculture side of the business this month and looks good stuff.

[m.t.glass] 09/9/2004 15:57

Dunno. I was reasonably convinced it might have bottomed at 42.5p, but apparently not ;o(

[relwood] 09/9/2004 11:27

I have been watch this for sometime but have not bought. I am surprised that the price keeps slipping despite good news. Do you have comments as to the consistent fall?? How low will this go?

[tony5505] 09/9/2004 00:27

Micap gets a mention in todays shares mag regarding the mrsa superbug. It's quite a large article and at least it's not negative towards Micap.

[leeming] 29/8/2004 08:54

Hi all,
Have been slowly accumulating in recent months.Feel the Co progressing
well and a reasonable investment.
One point that somebody on this board may help me with:
Is there a stock overhang?
Recent news ought to have pushed the share price towards the float price.
I realise many Bios have slipped in the last quarter but I just wonder
with MIC.

[m.t.glass] 25/8/2004 11:08

Aims and Scope:

The Journal of Microencapsulation is a well-established journal devoted to the preparation, properties and uses of individually encapsulated small particles. Its scope extends beyond microcapsules to all other small particulate systems which involve preparative manipulation. These forms find a wide variety of medical, biological, industrial and research applications. The journal covers the chemistry of encapsulation materials; the physics of release through the capsule wall; the techniques of preparation; content and storage; and the many uses to which microcapsules are put. Also found in every issue of the journal is an extensive information and reference section comprising patent briefing and literature alerts listings.

Readership:

Academics and industrialists in the fields of pharmaceutical science, medicine, photographic and copying processes, food technology, agrochemicals, adhesives and all those interested in small particle science and technology.

Abstracting Information:

Journal of Microencapsulation is covered by the following abstracting and indexing services: BIOSIS, Cambridge Scientific Abstracts, Chemical Abstracts, Current Contents: Life Sciences, EBSCO Online, Engineering Technology and Applied Sciences, Excerpta Medica/EMBASE, Index Medica/MEDLINE, Medical Documentation Service, Repra Technology Ltd, Research Alert, Science Citation Index, SciSearch, SUBIS and UnCover.

taken from
--------------------------------------------------------------
Google throws up over 28,000 responses to the word microencapsulation. A busy field!

[mintyfool] 25/8/2004 10:52

Small tick-up on the convertible to 6p offered. First signs of life in a while.

mf

[jojobubba] 25/8/2004 09:15

Wow, this company continues to suprise! Now we just need some positive results published and we will be away.

[m.t.glass] 25/8/2004 09:01

Many thanks eibbor - very interesting. Looks like the concept of persistent antimicrobials is well established already. Though I notice this:

"..Microban technology is not designed to protect users from disease-causing microorganisms..."

So there is obviously further scope.

mtg

[mintyfool] 25/8/2004 08:55

beckaroo,

I haven't read the detailed conditions, but I would assume they could be exercised on a change of control. Importantly, Sigma Technology who are one of the largest shareholders is also the largest convertible holder. Neil Crabbe of Sigma is on Micap's board. This would ensure full value for the convertible. That said, I would be very surprised if Micap is bought at this early stage.

The value of the convertible is, like all other equity related investments, a function of supply and demand in the short term. If you compare the charts of the ordinary shares and the converts, you will see that the convert lagged the rise in the ords before making a large leap. Similarly, the fall was delayed also. Liquidity is poor at the moment, but if the ords take off then the converts will become more liquid and will trade more in line with the ords.

Hope this helps.

mf

[eibbor] 25/8/2004 08:51

I'm not a plastics expert MT but I see (and own) products labeled 'Microban' which I guess is a simillar idea. Things like plastic chopping boards, dish washing brushes, loo brushes etc.

here you go